These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 34062254)
1. Interrelationship between the 5-lipoxygenase pathway and microbial dysbiosis in the progression of Alzheimer's disease. Mathis SP; Bodduluri SR; Haribabu B Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158982. PubMed ID: 34062254 [TBL] [Abstract][Full Text] [Related]
2. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease. Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684 [TBL] [Abstract][Full Text] [Related]
3. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease. Goyal D; Ali SA; Singh RK Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638 [TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease. Nagu P; Parashar A; Behl T; Mehta V J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390 [TBL] [Abstract][Full Text] [Related]
5. Gut microbiota regulate Alzheimer's disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Chen C; Liao J; Xia Y; Liu X; Jones R; Haran J; McCormick B; Sampson TR; Alam A; Ye K Gut; 2022 Nov; 71(11):2233-2252. PubMed ID: 35017199 [TBL] [Abstract][Full Text] [Related]
6. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model. Kim MS; Kim Y; Choi H; Kim W; Park S; Lee D; Kim DK; Kim HJ; Choi H; Hyun DW; Lee JY; Choi EY; Lee DS; Bae JW; Mook-Jung I Gut; 2020 Feb; 69(2):283-294. PubMed ID: 31471351 [TBL] [Abstract][Full Text] [Related]
7. Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice. Chilton PM; Ghare SS; Charpentier BT; Myers SA; Rao AV; Petrosino JF; Hoffman KL; Greenwell JC; Tyagi N; Behera J; Wang Y; Sloan LJ; Zhang J; Shields CB; Cooper GE; Gobejishvili L; Whittemore SR; McClain CJ; Barve SS Gut Microbes; 2024; 16(1):2389319. PubMed ID: 39182227 [TBL] [Abstract][Full Text] [Related]
8. NMN synbiotics intervention modulates gut microbiota and metabolism in APP/PS1 Alzheimer's disease mouse models. Zhang J; Zhao X; Xu H; Liu X; He Y; Tan X; Gu J Biochem Biophys Res Commun; 2024 Sep; 726():150274. PubMed ID: 38924882 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Gut Microbe Dysbiosis on the Pathogenesis of Alzheimer's Disease (AD) and Related Conditions. Nafady MH; Sayed ZS; Abdelkawy DA; Shebl ME; Elsayed RA; Ashraf GM; Perveen A; Attia MS; Bahbah EI Curr Alzheimer Res; 2022; 19(4):274-284. PubMed ID: 35440296 [TBL] [Abstract][Full Text] [Related]
10. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies. Shabbir U; Arshad MS; Sameen A; Oh DH Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988 [TBL] [Abstract][Full Text] [Related]
11. The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings. Yang J; Liang J; Hu N; He N; Liu B; Liu G; Qin Y CNS Neurosci Ther; 2024 Oct; 30(10):e70091. PubMed ID: 39460538 [TBL] [Abstract][Full Text] [Related]
12. Novelties on Neuroinflammation in Alzheimer's Disease-Focus on Gut and Oral Microbiota Involvement. Popescu C; Munteanu C; Anghelescu A; Ciobanu V; Spînu A; Andone I; Mandu M; Bistriceanu R; Băilă M; Postoiu RL; Vlădulescu-Trandafir AI; Giuvara S; Malaelea AD; Onose G Int J Mol Sci; 2024 Oct; 25(20):. PubMed ID: 39457054 [TBL] [Abstract][Full Text] [Related]
13. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease. Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007 [TBL] [Abstract][Full Text] [Related]
14. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease. Shukla PK; Delotterie DF; Xiao J; Pierre JF; Rao R; McDonald MP; Khan MM Cells; 2021 Apr; 10(4):. PubMed ID: 33916001 [TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment. Liu S; Gao J; Zhu M; Liu K; Zhang HL Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453 [TBL] [Abstract][Full Text] [Related]
16. Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer's disease. Qian XH; Liu XL; Chen G; Chen SD; Tang HD J Neuroinflammation; 2022 Sep; 19(1):236. PubMed ID: 36171620 [TBL] [Abstract][Full Text] [Related]
17. Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer's disease progression. Das TK; Ganesh BP Gut Microbes; 2023; 15(1):2206504. PubMed ID: 37127846 [TBL] [Abstract][Full Text] [Related]
18. Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway. Xu QQ; Su ZR; Yang W; Zhong M; Xian YF; Lin ZX J Neuroinflammation; 2023 Jan; 20(1):19. PubMed ID: 36717922 [TBL] [Abstract][Full Text] [Related]
19. Dysbiosis and Alzheimer's Disease: Cause or Treatment Opportunity? Janeiro MH; Ramírez MJ; Solas M Cell Mol Neurobiol; 2022 Mar; 42(2):377-387. PubMed ID: 33400081 [TBL] [Abstract][Full Text] [Related]
20. Intestinal microbial dysbiosis aggravates the progression of Alzheimer's disease in Drosophila. Wu SC; Cao ZS; Chang KM; Juang JL Nat Commun; 2017 Jun; 8(1):24. PubMed ID: 28634323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]